2nd Quarter - Report

BGR GOVERNMENT AFFAIRS for NOVARTIS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide strategic counsel and advocacy for issues related to policies impacting the pharmaceutical industry generally including drug shortages, patient out of pocket costs, supply chain, PBM policies, Inflation Reduction Act, cell, gene and radioligand therapies, and/or issues impacting Novartis specifically

LobbyistCovered position, as disclosed
JOEL D. BAILEY See prior filing
BRENT ALAN DEL MONTE See prior filing
DANIEL FARMER See prior filing
REMY LEIGH BRIM MASON See prior filing
JOHN STONE See prior filing
ROBB WALTON See prior filing

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.